About Conifer Point
Conifer Point is a company based in Doylestown (United States) founded in 2015 was acquired by Lodo Therapeutics in August 2020. Conifer Point offers products and services including Boltzmann Maps and Computational Chemistry Services. Conifer Point operates in a competitive market with competitors including Aganitha, Cellumen, Emergentec, PointCross and IOTA Pharma, among others.
- Headquarter Doylestown, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$2.94 M (USD), Grant
Jul 01, 2020
-
Investors
HHS
& 1 more
-
Employee Count
Not available
-
Acquired by
Lodo Therapeutics
(Aug 07, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Conifer Point
Conifer Point offers a comprehensive portfolio of products and services, including Boltzmann Maps and Computational Chemistry Services.
Web application for designing and prioritizing small molecules in pre-clinical drug discovery.
Services to design, improve, and screen compounds for targeted drug research applications.
Funding Insights of Conifer Point
Investors in Conifer Point
Conifer Point has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Lodo Therapeutics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
Developer novel therapeutics to treat resistant infectious diseases and cancers using AI
|
Locked | Locked | Locked |
Investor details for Conifer Point
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Conifer Point
Investment portfolio details for Conifer Point
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Conifer Point
Detailed financials for Conifer Point
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Conifer Point Comparisons
Peer comparison for Conifer Point
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Conifer Point
Conifer Point operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Aganitha, Cellumen, Emergentec, PointCross and IOTA Pharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of AI-powered drug discovery and development solutions
|
|
| Locked | Locked | Locked |
Systems biology solutions for drug safety and efficacy are provided.
|
|
| Locked | Locked | Locked |
Computational solutions and consulting for better decision making in biomarker, target and drug development.
|
|
| Locked | Locked | Locked |
Big data platform & desktop software for preclinical & clinical research & regulatory applications
|
|
| Locked | Locked | Locked |
Offers fragment-based drug discovery products and services.
|
|
| Locked | Locked | Locked |
Offers AI and machine learning for in-silico drug discovery and bioinformatics services.
|
Detailed competitors of Conifer Point
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Conifer Point
Complete news archive for Conifer Point
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Conifer Point
Conifer Point was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Conifer Point is headquartered in Doylestown, United States. It is registered at Doylestown, Pennsylvania, United States.
Developer of new drugs using custom fragment-based drug design software. Services offered include molecular dynamics simulations, quantum mechanical simulations, hot-spot mapping, and water mapping. The pipeline includes renin and DHFR in a hit to lead stage for hypertension and gram-negative bacteria, d-ala-d-ala ligase for tuberculosis and gram-negative bacteria in the hit validation stage, and PD-1 for immuno-oncology in the computational chemistry stage.
Conifer Point's top competitors include Aganitha, Cellumen and PointCross.
Conifer Point offers Boltzmann Maps and Computational Chemistry Services.
Conifer Point has 2 investors. Key investors include HHS, and Lodo Therapeutics.